Pancreatic signet ring cell adenocarcinoma

Summary

Pancreatic signet ring cell adenocarcinoma (MONDO:0002666) is a disease. A subtype of signet ring cell carcinoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	pancreatic signet ring cell adenocarcinoma
Mondo ID	MONDO:0002666
DOID	DOID:3497
NCIT	C5720
UMLS	C1335317
MedGen	233834
GARD	0027610
Anatomy (UBERON)	UBERON:0001264
Is cancer (heuristic)	no

Also known as: pancreas signet ring cell carcinoma · pancreatic signet Ring cell carcinoma · pancreatic signet ring cell carcinoma · signet Ring cell carcinoma of pancreas · signet Ring cell carcinoma of the pancreas

Disease family

This is a subtype of signet ring cell carcinoma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › cancer › carcinoma › adenocarcinoma › signet ring cell carcinoma › pancreatic signet ring cell adenocarcinoma

Related subtypes (10): extrahepatic bile duct signet ring cell carcinoma, gallbladder signet ring cell adenocarcinoma, signet ring cell breast carcinoma, acinar prostate adenocarcinoma, signet ring variant, signet ring cell variant cervical mucinous adenocarcinoma, bladder signet ring cell adenocarcinoma, Krukenberg carcinoma, lung signet ring cell carcinoma, signet ring cell gastric adenocarcinoma, colorectal signet ring cell carcinoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.